EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA

This adverse event was reported 591 times

These drugs are most commonly taken by patients reporting EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA:

# Drug Count
0 MYCOPHENOLATE MOFETIL 166
1 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 166
2 PREDNISONE 145
3 METHOTREXATE SODIUM 142
4 METHOTREXATE 122
5 TACROLIMUS 108
6 TACROLIMUS EXTENDED-RELEASE CAPSULES 100
7 TACROLIMUS OINTMENT 0.1% 100
8 PREDNISOLONE 99
9 PREDNISOLONE ORAL 99
See all common drugs associated with EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA

EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SELADELPAR LYSINE 1 0.0036
1 IDARUBICIN HYDROCHLORIDE 4 0.0035
2 PRALATREXATE 2 0.0031
3 MEGNESIUM OXIDE 1 0.0024
4 CLOFARABINE 5 0.0022
5 FLUCYTOSINE 3 0.0021
6 ALEMTUZUMAB 36 0.0019
7 MECHLORETHAMINE HYDROCHLORIDE 4 0.0018
8 PYRIMETHAMINE 2 0.0016
9 BASILIXIMAB 16 0.0013
See all drugs enriched for association with EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA